Fig. 7
From: VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy
Electroretinographic (ERG) analysis of the effects of CB-5083 on retinal function. A, B ERG analysis of photoresponse (ERG A-wave component) latency showed no differences between vehicle and CB-5083 treatment in both WT and VCPR155H/R155H mice. D, E ERG analysis of photoresponse (ERG A-wave component) amplitude showed no differences between vehicle and CB-5083 treatment in both WT and VCPR155H/R155H mice. Statistical analysis was performed by one-way ANOVA followed by Fisher’s LSD test